Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.630440
Abstract: T-cell products derived from third-party donors are clinically applied, but harbor the risk of off-target toxicity via induction of allo-HLA cross-reactivity directed against mismatched alleles. We used third-party donor-derived virus-specific T cells as model to…
read more here.
Keywords:
hla cross;
allo hla;
third party;
hla ... See more keywords